Carl Hansen is just about ready to grab the key to the exclusive Covillionaire club
It looks like AbCellera CEO Carl Hansen is set to join the Covillionaire club this week.
The antibody discovery outfit filed its updated S-1 on Monday, putting the range for the share price at $14 to $17. That pegs the market cap at the mid-range right around $5 billion, and Hansen has kept hold of what will be a 23% stake in the company, controlling 61,827,830 shares. And AbCellera is poised to haul in more than $400 million from the latest blockbuster IPO to hit Wall Street.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 107,200+ biopharma pros reading Endpoints daily — and it's free.